[go: up one dir, main page]

Jump to content

Napactadine

From Wikipedia, the free encyclopedia
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Napactadine
Clinical data
Other namesDL-588
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC14H16N2
Molar mass212.296 g·mol−1
3D model (JSmol)
  • CNC(=NC)CC1=CC2=CC=CC=C2C=C1
  • InChI=1S/C14H16N2/c1-15-14(16-2)10-11-7-8-12-5-3-4-6-13(12)9-11/h3-9H,10H2,1-2H3,(H,15,16)
  • Key:NAHCWQNNENHGNH-UHFFFAOYSA-N

Napactadine is an antidepressant which has structural properties that look similar to PAL-287 or methamnetamine, but is based on an amidine functional group.[1]

Synthesis

The synthesis of napactadine has been described:[2][3]

Napactadine synthesis
Napactadine synthesis

Reaction of N-methyl-2-(naphthalen-2-yl)acetamide [2086-65-9] (1) with triethyloxonium fluoroborate (Meerwein reagent) [368-39-8] (2) affords the corresponding imino ether (3). Exposure of this intermediate to methylamine (4) leads to napactidine (5).

References

  1. ^ Castañer J, Hillier K (1981). "DL-588". Drugs of the Future. 6 (6): 348. doi:10.1358/dof.1981.006.06.1003976.
  2. ^ McCarthy JR, Wright DL, Schuster AJ, Abdallah AH, Shea PJ, Eyster R (November 1985). "New bicyclic antidepressant agent. Synthesis and activity of napactadine and related compounds". Journal of Medicinal Chemistry. 28 (11): 1721–7. doi:10.1021/jm00149a031. PMID 4067998.
  3. ^ Jr James R Mccarthy, US3903163 (1975 to Dow Chemical Co).